Methods for inhibiting bone loss
作者： Larry J. Black , George J. Cullinan
DOI:
关键词:
摘要: The current invention provides methods and pharmaceutical formulations that are useful for inhibiting the loss of bone. These can be used without associated adverse effects estrogen therapy, thus serve as an effective acceptable treatment osteoporosis.
lens.org参考文章(131)
Patrick Daniel Kelly, Sexual lubricants containing zinc as an anti-viral agent ,(1991)
J. Simard, R. Veilleux, M. Dufour, F. Labrie, Y. De Launoit, Characteristics of the Biphasic Action of Androgens and of the Potent Antiproliferative Effects of the New Pure Antiestrogen EM-139 on Cell Cycle Kinetic Parameters in LNCaP Human Prostatic Cancer Cells Cancer Research. ,vol. 51, pp. 5165- 5170 ,(1991)
Na N. Yang, Method for screening anti-osteoporosis agents ,(1993)
Tulio Suarez, C. David Jones, 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents ,(1976)
Stephanie A. Sweetana, David E. Magee, Arvind L. Thakkar, Henry U. Bryant, Paul C. Francis, George J. Cullinan, Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof ,(1995)
Rosa Armstrong, Steven W. Adams, David Rosen, Bone growth factors and inhibitors of bone resorption for promoting bone formation ,(1992)
Janet Mary Hock, Parathyroid Hormone and Raloxifene for Increasing Bone Mass ,(1994)
Jeffrey Alan Dodge, Masahiko Sato, Methods of inhibiting vascular restenosis ,(1994)
Michael William Draper, George Joseph Cullinan, David Edward Seyler, Larry John Black, Charles David Jones, Methods of inhibiting uterine fibrosis ,(1994)
Richard Poulin, Fernand Labrie, Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Research. ,vol. 46, pp. 4933- 4937 ,(1986)